Page last updated: 2024-08-24

triazoles and tavaborole

triazoles has been researched along with tavaborole in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's18 (94.74)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Lipner, S; Scher, RK1
Fraser, K1
Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA1
Bhatia, N; Friedlander, SF; Gupta, AK; Kircik, L; Rosen, T; Stein Gold, L; Zirwas, MJ1
Hussar, DA1
Chanda, S; Coronado, D; Merchant, T; Vlahovic, TC; Zane, LT1
Dorval, E; Grace, Y; Machin, JD; Poulakos, M1
Rosen, T; Stein Gold, LF3
Chanda, S; Coronado, D; Del Rosso, J; Zane, LT1
Lagrew, JP1
Elewski, BE1
Koski, R; Maki, K; Nybo, SE; Saunders, J1
Adigun, CG; Gellings Lowe, N; Hall, SB; Joseph, WS; Rich, P; Vlahovic, TC; Zane, LT1
Ilie, C; Pollak, RA1
Lipner, SR; Scher, RK1
Ko, D; Lipner, SR1
Lipner, SR; Wang, Y1

Reviews

7 review(s) available for triazoles and tavaborole

ArticleYear
What is new in fungal pharmacotherapeutics?
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:4

    Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles

2014
Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:3

    Topics: Anti-Infective Agents, Local; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Onychomycosis; Pharmaceutical Solutions; Treatment Outcome; Triazoles

2015
New drugs 2015, part 3.
    Nursing, 2015, Volume: 45, Issue:10

    Topics: Acids, Carbocyclic; Benzoxazines; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cephalosporins; Cyclopentanes; Drug Approval; Drug Combinations; Drug Therapy; Glucagon-Like Peptides; Guanidines; Humans; Imidazoles; Immunoglobulin Fc Fragments; Interferon-beta; Isoquinolines; Penicillanic Acid; Polyethylene Glycols; Pyridines; Quinuclidines; Recombinant Fusion Proteins; Tazobactam; Triazoles; United States; United States Food and Drug Administration

2015
Efinaconazole and Tavaborole.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:2

    Topics: Administration, Topical; Animals; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Foot Dermatoses; Humans; Microbial Sensitivity Tests; Onychomycosis; Triazoles

2017
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Dermatology online journal, 2016, Mar-16, Volume: 22, Issue:3

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2016
Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:6

    Topics: Administration, Topical; Animals; Antifungal Agents; Arthrodermataceae; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

2017
Onychomycosis: Treatment and prevention of recurrence.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles

2019

Trials

2 trial(s) available for triazoles and tavaborole

ArticleYear
A financial perspective on the topical treatment of onychomycosis.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Onychomycosis; Risk Assessment; Treatment Outcome; Triazoles

2016
Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole
    Journal of drugs in dermatology : JDD, 2017, 12-01, Volume: 16, Issue:12

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles; Young Adult

2017

Other Studies

10 other study(ies) available for triazoles and tavaborole

ArticleYear
Onychomycosis: current and future therapies.
    Cutis, 2014, Volume: 93, Issue:2

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2014
72nd annual meeting of the American Academy of Dermatology.
    American journal of clinical dermatology, 2014, Volume: 15, Issue:2

    Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States

2014
Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
    Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:1

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Nails; Onychomycosis; Triazoles

2016
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States

2016
Introduction.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Foot Dermatoses; Humans; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles

2016
Using Topical Antifungal Medications: Instructions for patients.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Drug Administration Schedule; Foot Dermatoses; Humans; Onychomycosis; Pyridones; Triazoles

2016
Response to "A financial perspective on the topical treatment of onychomycosis".
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cost-Benefit Analysis; Drug Costs; Female; Foot Dermatoses; Humans; Male; Onychomycosis; Sensitivity and Specificity; Severity of Illness Index; Triazoles

2016
Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practice.
    Cutis, 2017, Volume: 100, Issue:4

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials, Phase III as Topic; Drug Approval; Humans; Onychomycosis; Pyridones; Research Design; Treatment Outcome; Triazoles; United States

2017
Optimizing topical therapy for onychomycosis: the importance of patient education.
    Cutis, 2018, Volume: 102, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Humans; Medication Adherence; Onychomycosis; Patient Education as Topic; Triazoles

2018
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Archives of dermatological research, 2020, Volume: 312, Issue:8

    Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Erythema; Humans; Nails; Onychomycosis; Pigmentation; Retrospective Studies; Solutions; Treatment Failure; Triazoles; United States; United States Food and Drug Administration

2020